http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112156111-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2509-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078 |
| filingDate | 2020-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112156111-B |
| titleOfInvention | Application of umbilical cord blood platelet mitochondria in the preparation of drugs for the treatment of autoimmune diseases |
| abstract | The invention discloses the application of umbilical cord blood platelet mitochondria in the preparation of medicines for treating autoimmune diseases. The platelet mitochondria separated from the cord blood are used for preparing medicines for treating autoimmune diseases. The application of the medicine for treating autoimmune diseases prepared by using cord blood platelet mitochondria of the present invention has the advantages of good therapeutic effect, less side effects, easy preservation of cord blood platelet mitochondria, and stable function of mitochondria. Through in vivo and in vitro experiments, the results show that cord blood platelet mitochondria have obvious therapeutic effects on autoimmune diseases. |
| priorityDate | 2020-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.